Importance of Monitoring
- Early detection of endometrial hyperplasia.
- Monitoring abnormal changes in tissue morphology.
- Excluding uterine polyps caused by drug stimulation.
- Providing a baseline for future comparative studies.
Book Endometrial Monitoring for Tamoxifen Users | Lahalak Medical Platform
Ensure your safety during Tamoxifen therapy with periodic endometrial thickness monitoring. This essential screening helps detect early changes like hyperplasia or polyps, providing peace of mind and ensuring your treatment remains safe.
Scientific name: Endometrial Monitoring for Tamoxifen Users
A precise transvaginal ultrasound screening to monitor endometrial thickness and morphology in patients on Tamoxifen therapy. It aims to detect early hyperplasia or polyps, ensuring timely medical intervention and treatment safety.
Service type
Ultrasound Imaging
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Transvaginal Ultrasound (TVUS)
- Precise endometrial thickness measurement
- Detailed medical report
Medical Service Information
Target Groups
- Women taking Tamoxifen as part of breast cancer treatment.
- Patients experiencing abnormal vaginal bleeding during therapy.
- High-risk cases requiring routine oncological follow-up.
Frequently Asked Questions
- Is the procedure painful? No, transvaginal ultrasound is a simple and painless procedure.
- How often should I be tested? Typically every 6 to 12 months or as directed by your doctor.
- Are there special preparations? No fasting is required; just an empty bladder is preferred.
Conditions & Notices
- Preferably performed immediately after the menstrual cycle
- Bring previous reports for comparison
Medical services you might also like
